Rigas, J.R., Denham, C.A., Rinaldi, D., Moore, T., Smith II, J.W., Winston, R.D. and Humphrey, R. (2003) O-107 Adjuvant Targeted Therapy in Unresectable Lung Cancer: The Results of Two Randomized Placebo-Controlled Trials of Bay 12-9566, a Matrix Metalloproteinase Inhibitor [MMPI]. Lung Cancer, 41, S34. http://dx.doi.org/10.1016/S0169-5002(03)91765-X

has been cited by the following article:

• TITLE: Missing the Target?—Targeted Therapy in Small Cell Lung Cancer

  AUTHORS: Karin R. Purshouse

  KEYWORDS: Oncology, Small Cell Lung Cancer, Targeted Therapy, Drug Development

  JOURNAL NAME: Advances in Lung Cancer, Vol.3 No.3, August 22, 2014

  ABSTRACT: Small cell lung cancer [SCLC] is a devastating form of cancer, with most patients harbouring extensive disease at diagnosis and survival of less than 5% at five years. Progress in novel therapies has been limited. This specialist review explores current targeted therapy options and potential areas of development.